TMCnet News

Uveitis - Pipeline Review, H1 2016 - Research and Markets

[May 19, 2016]

Uveitis - Pipeline Review, H1 2016 - Research and Markets

Research and Markets has announced the addition of the "Uveitis - Pipeline Review, H1 2016" report to their offering.

This report provides comprehensive information on the therapeutic development for Uveitis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Uveitis and special features on late-stage and discontinued projects.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Key Topics Covered:

Introduction

Uveitis Overview

Therapeutics Development

Pipeline Products for Uveitis - Overview

Pipeline Products for Uveitis - omparative Analysis

Uveitis - Therapeutics under Development by Companies

Uveitis - Therapeutics under Investigation by Universities/Institutes

Uveitis Products Glance

Late Stage Products

Clinical Stage Products

Early Stage Products